ArticleDiseases (Basel, Switzerland)2022

Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers.

Camilla Heiniö et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.